Angiocard SRL
Angiocard reported total assets of 136,943 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Angiocard shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets -23 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Angiocard's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 22,525 € | ||||
| Equity | 109,432 € | ||||
| Cash | 84,425 € | ||||
| EBITDA | 41,376 € | ||||
| Total assets | 136,943 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 16 Aug 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
Angiocard's financial analysis
- Solvency79.9%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Angiocard
Angiocard's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0470.019.438
- VAT number
- BE0470019438
- Peppol
- Registered · 0208:0470019438 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jan 2000
- Registered office
- 4052 Chaudfontaine
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Angiocard (SRL) has been based in Chaudfontaine since 2000, active in: medical specialists activities. For 2025, it reports a net profit of 22,525 € and equity of 109,432 €; its revenue is not published. Its solvency stands at 79.9%, above the median of its sector (65.0%).
Companies similar to Angiocard
Companies in the same business, of comparable size and area, outside its group.
- Dokter Eric Tack Public relations and communication activities Waasmunster · balance sheet 872,088 €
- Bremptallergy Business and other management consultancy activities Marche-en-Famenne · balance sheet 224,849 €
- Caduceus Business and other management consultancy activities Uccle · balance sheet 91,247 €
- Dr Gigot expertises et conseils Public relations and communication activities Incourt · balance sheet 280,782 €
- Reunite Medical specialists activities Bruges · balance sheet 202,070 €
- Docteur Gilles CEYSENS Medical specialists activities Mons · balance sheet 192,563 €
- MédiStreel Medical specialists activities Sainte-Ode · balance sheet 137,789 €
- Dr O DETRY Medical specialists activities Liège · balance sheet 320,967 €
Frequently asked questions about Angiocard
What is the revenue of Angiocard?
Angiocard files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Angiocard?
In Belgium, the VAT number is the company number prefixed with BE: BE0470019438 for Angiocard, if the company is VAT-registered. Its company number (CBE) is 0470.019.438.
Where is the registered office of Angiocard?
According to the CBE register, the registered office of Angiocard is in 4052 Chaudfontaine.
What is the equity of Angiocard?
At the close of the 2025 financial year, the equity of Angiocard amounts to 109,432 €, a solvency of 79.9% of total assets.
Who manages Angiocard?
The register lists 2 active mandates at Angiocard. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Angiocard
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →